{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:42:54Z","timestamp":1782783774605,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ctro.2020.11.001","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:14:17Z","timestamp":1604600057000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment"],"prefix":"10.1016","volume":"26","author":[{"given":"Melissa","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"De Roover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schalk","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Defraene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2020.11.001_b0005","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2020.11.001_b0010","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0015","unstructured":"National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, NCCN Guidelines Version 2.2020: Esophageal and Esophagogastric Junction Cancers 2020."},{"key":"10.1016\/j.ctro.2020.11.001_b0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1245\/s10434-013-3316-8","article-title":"Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients","volume":"21","author":"Bosch","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jtcvs.2006.05.015","article-title":"Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy","volume":"132","author":"Reynolds","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ctro.2020.11.001_b0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0360-3016(03)01373-7","article-title":"Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose\u2013volume histogram parameters","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijrobp.2005.08.002","article-title":"Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery","volume":"64","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijrobp.2006.06.002","article-title":"Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery","volume":"66","author":"Tucker","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0045","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijrobp.2011.12.018","article-title":"Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation","volume":"83","author":"Hatakenaka","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.radonc.2005.10.017","article-title":"Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer","volume":"77","author":"Chandra","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0055","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ijrobp.2011.10.053","article-title":"Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer","volume":"83","author":"Kole","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0060","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.07.2001","article-title":"Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study","volume":"81","author":"Welsh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.07.034","article-title":"Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or intensity-modulated radiation therapy","volume":"125","author":"Shiraishi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0070","doi-asserted-by":"crossref","first-page":"866","DOI":"10.14338\/IJPT-14-00018.1","article-title":"Comparing proton beam to intensity modulated radiation therapy planning in esophageal cancer","volume":"1","author":"Wang","year":"2015","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ctro.2020.11.001_b0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.semradonc.2003.10.003","article-title":"Errors and margins in radiotherapy","volume":"14","author":"van Herk","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0080","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1088\/0031-9155\/57\/11\/R99","article-title":"Range uncertainties in proton therapy and the role of Monte Carlo simulations","volume":"57","author":"Paganetti","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2020.11.001_b0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/02841861003652574","article-title":"Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy","volume":"49","author":"Yamashita","year":"2010","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ctro.2020.11.001_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2010.11.002","article-title":"Set-up errors in radiotherapy for oesophageal cancers \u2013 is electronic portal imaging or conebeam more accurate?","volume":"98","author":"Hawkins","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0095","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ijrobp.2012.07.2358","article-title":"Detection of esophageal fiducial marker displacement during radiation therapy with a 2-dimensional on-board imager: analysis of internal margin for esophageal cancer","volume":"85","author":"Fukada","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1442-2050.2009.01037.x","article-title":"Esophageal motion during radiotherapy: quantification and margin implications","volume":"23","author":"Cohen","year":"2010","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ctro.2020.11.001_b0105","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aacfb5","article-title":"Quantification of variations in intra-fraction motion of esophageal tumors over the course of neoadjuvant chemoradiotherapy based on cine-MRI","volume":"63","author":"Heethuis","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2020.11.001_b0110","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.ijrobp.2011.12.048","article-title":"Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer","volume":"83","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2015.10.005","article-title":"Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer","volume":"117","author":"Jin","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2019.04.014","article-title":"Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping","volume":"136","author":"Hoffmann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2018.12.016","article-title":"Utility of fiducial markers for target positioning in proton radiotherapy of oesophageal carcinoma","volume":"133","author":"Apolle","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0130","article-title":"Quantification of esophageal tumor motion on cine-magnetic resonance imaging","author":"Lever","year":"201488419","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0135","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.crad.2018.02.006","article-title":"Tumour motion of oesophageal squamous cell carcinoma evaluated by cine MRI: associated with tumour location","volume":"73","author":"Zhou","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ctro.2020.11.001_b0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijrobp.2010.03.045","article-title":"Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer","volume":"79","author":"Yamashita","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2017.05.015","article-title":"Interfractional variability of respiration-induced esophageal tumor motion quantified using fiducial markers and four-dimensional cone-beam computed tomography","author":"Jin","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.gie.2015.03.1972","article-title":"Endoscopy\/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers","volume":"82","author":"Machiels","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ctro.2020.11.001_b0155","series-title":"Oesophagus (ICD-O-3 C15) \u2013 including oesophagogastric junction (C16). UICC TNM classification of malignant tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.ctro.2020.11.001_b0160","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0360-3016(00)00518-6","article-title":"The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy","volume":"47","author":"van Herk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semradonc.2005.01.007","article-title":"Computed tomography guided management of interfractional patient variation","volume":"15","author":"Yan","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jrr\/rrt071","article-title":"Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy","volume":"54","author":"Habermehl","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ctro.2020.11.001_b0175","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1120\/jacmp.v10i1.2875","article-title":"Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer","volume":"10","author":"Giebeler","year":"2009","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2007.07.008","article-title":"Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction","volume":"84","author":"Zhao","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.11.001_b0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijrobp.2008.05.014","article-title":"Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer","volume":"72","author":"Zhang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.11.001_b0190","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijrobp.2008.12.060","article-title":"Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer","volume":"74","author":"Patel","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:07:48Z","timestamp":1762502868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630820300884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"alternative-id":["S2405630820300884"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2020.11.001","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}